CLB101™ is the first and only Anaerostipes caccae probiotic commercially available for functional formulations. A strict anaerobe and one of the few direct butyrate-producers, CLB101™ defines a new frontier in next generation probiotics driven by cutting-edge microbiome research and innovative biotechnology.

CLB101™ has achieved GRAS self-affirmation, and is NDI exempt since it is found in the food supply, and is thus available for commercial use as a dietary supplement in the United States.

We maintain a strong partnership with a food-grade, GMP-certified manufacturer. Their expertise in anaerobic fermentation, downstream processing, and formulation enables us to deliver high-quality live bacterial products that effectively support our targeted delivery approach.

CLB101™ is a naturally occurring strain isolated from healthy humans. It has been extensively studied in toxicology and efficacy studies in animals, and a human clinical study is underway.